Radiopharmaceuticals Market Growth Drivers, and Competitive Landscape

According to the latest market research report title “Radiopharmaceuticals Market By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Gallium 68, Iodine 123, Others), By Indication (Oncology, Cardiology, Gastroenterology, Nephrology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals, Medical Imaging Centers) and Others--Forecast to 2030″, published by MarkNtel Advisors, The Global Radiopharmaceuticals Market is estimated to grow at a CAGR of around 10.02% during the forecast period, i.e., 2024-30.

The data present in the report exhibit from the historic years (2019-22) and the base year (2023) to put together estimations for the forecast period (2024-30). In the study, our researchers put together reliable, unbiased, and accurate data to enlighten investors about fluctuations in the industry & anticipations on what to expect in the future. Since the industry is dynamic and highly fragmented, this report enables the prominent players to make strategic moves associated with their investments in the coming years.

Request for Sample Report: https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Global Radiopharmaceuticals Market Driver:

Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.

With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals

Radiopharmaceuticals Market Segmentation

The Radiopharmaceuticals Market is highly robust and fragmented into numerous segments;

By Radioisotope

-Technetium 99- Market Size & Forecast 2019-2030, USD Million

-Fluorine 18- Market Size & Forecast 2019-2030, USD Million

-Iodine 131- Market Size & Forecast 2019-2030, USD Million

-Gallium 68- Market Size & Forecast 2019-2030, USD Million

-Iodine 123- Market Size & Forecast 2019-2030, USD Million

-Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD Million

By Indication

-Oncology- Market Size & Forecast 2019-2030, USD Million

-Cardiology- Market Size & Forecast 2019-2030, USD Million

-Gastroenterology- Market Size & Forecast 2019-2030, USD Million

-Nephrology- Market Size & Forecast 2019-2030, USD Million

-Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030, USD Million

By Type

-Diagnostic- Market Size & Forecast 2019-2030, USD Million

-Therapeutic- Market Size & Forecast 2019-2030, USD Million

By End User

-Hospitals- Market Size & Forecast 2019-2030, USD Million

-Medical Imaging Centers- Market Size & Forecast 2019-2030, USD Million

-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million

By Region

-North America

-South America

-Europe

-The Middle East & Africa

-Asia-Pacific

Click here for a more detailed explanation: https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

Key Players Operating in the Radiopharmaceuticals Market: -

Northstar Medical Technologies LLC

-Business Description

-Radioisotope Portfolio

-Strategic Alliances or Partnerships

-Recent Developments

-Financial Details

-Others

IBA Radiopharma Solutions

-Business Description

-Radioisotope Portfolio

-Strategic Alliances or Partnerships

-Recent Developments

-Financial Details

-Others

Sun Pharmaceutical Industries, Inc.

-Business Description

-Radioisotope Portfolio

-Strategic Alliances or Partnerships

-Recent Developments

-Financial Details

-Others

Key Questions Answered:

• What is the projected CAGR of the Radiopharmaceuticals Market during the forecast period?
• Which segment is expected to lead the Radiopharmaceuticals Market?
• Who are the prominent players driving market growth?

Key Offerings:

• Market Share, Size, and Revenue Forecast
• Market Dynamics: Growth drivers, restraints, investment opportunities, and key trends
• Landscape: Leading key players and other prominent participants

About MarkNtel Advisors

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Using such information, our clients can identify attractive investment opportunities & strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.

We understand the mounting & diverse needs of our clients. Hence, our analysts focus on emerging industries to provide services that fulfilled their assessment of the current & future industry potential, identify white spaces & hotspots, & venture into new geographies or business segments in the future.

Contact Us –

Call: ???? +1 628 895 8081, +91 120 4278433

Email: ???? sales@marknteladvisors.com   

Visit to know more: ???? www.marknteladvisors.com